The incidence of liver cancer in China is very high, because liver cancer is difficult to find in the early stage of the disease. Once the diagnosis is often in the middle and late stages, the optimal treatment time is often missed. The traditional treatment for liver cancer is surgery, radiotherapy and chemotherapy, etc. However, such treatment methods generally have a relatively high recurrence rate, and the survival rate of patients is relatively low. To prevent recurrence and metastasis of liver tumors, cell imunoterapija trenutno lahko poskusite.
Due to the limitation of liver tumor size, growth location, and relationship with the position of large blood vessels and biliary tract, some patients with special small liver cancer, huge liver tumor, and middle-advanced liver cancer with multiple metastatic lesions often lose the opportunity for surgery.
However, for these patients, the expert’s approach is to first use argon-helium ultra-cold knife minimally invasive treatment, through physical freezing and thawing to destroy the cell structure of tumor tissue in a short period of time, promote tumor tissue necrosis and close tumor small blood vessels. At the same time, combined with interventional therapy, embolization of tumor large vessels and local high-concentration chemotherapy, the combination of the two therapies can inhibit the growth of liver rakave celice and eliminate tumor lesions in a short period of time.
In general, most of the primary raka jeter are large undetectable liver cancers, which are accompanied by tumor thrombi in the internal and external portal vein system. The recurrence rate within one year after radiotherapy and chemotherapy is as high as 60%, and the 3-year survival rate is less than 30%. Therefore, the most important thing for liver cancer surgery is to prevent recurrence, but traditional radiotherapy and chemotherapy have large side effects, which can easily lead to liver cirrhosis and even liver function damage.
Relativno nova metoda zdravljenja - biološka celična imunost
(CIK celice) pomembno vplivajo na napredovali rak jeter. Ta terapija lahko pomaga očistiti preostale rakave celice v bolnikovem telesu, obnoviti bolnikovo imunsko funkcijo prepoznavanja in ubijanja rakavih celic ter tako preprečiti in nadzorovati metastaze tumorja.
Celice CIK so s citokini inducirane celice ubijalke, ki so mononuklearne celice, izolirane iz periferne krvi, kostnega mozga ali popkovnične krvi. Po določenem času v laboratoriju se inducirajo, razmnožijo in nato ponovno vnesejo v pacienta, da neposredno ubijejo kri. Tumorske celice v limfi tudi uravnavajo in krepijo bolnikovo imunsko funkcijo.
Glede na klinično statistiko je 9 bolnikov s 4. stopnjo raka jeter po operaciji podvrženih več kot 3 ciklom celične imunoterapije, kar lahko bolje prepreči ponovitev raka jeter po operaciji. Povprečni čas preživetja po zdravljenju je 20 mesecev, stopnja ponovitve v enem letu pa le 1 %, simptomi nelagodja pri večini bolnikov pa se izboljšajo.
Zgornje preprosto razumevanje preprečevanja ponovitve jetrnega tumorja in metastaz, lahko poskusite s celično imunoterapijo, celična imunoterapija je razmeroma nova metoda zdravljenja raka, kot je biološka celična imunoterapija, lahko pomaga bolnikom odstraniti ostanke rakavih celic v telesu, poleg imunosti Terapija vpliva na prepoznavanje in ubijanje rakavih celic, s čimer dodatno preprečuje širjenje in metastaziranje tumorjev.
